Innoviva (INVA) Net Margin (2011 - 2026)
Innoviva (INVA) reported Net Margin of -69.75% for Q2 2026, down 133.26 percentage points from 63.51% a year earlier and down 260.17 percentage points from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Net Margin (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Innoviva's Net Margin came in at 81.19%, up 70.75 percentage points year-over-year; for FY2025, it came in at 65.92%, up 59.40 percentage points from FY2024.
- Net Margin has a five-year change of -0.70 percentage points (FY2020 to FY2025).
- By year, Net Margin came in at 6.52% in FY2024 (-51.37 pp), 57.89% in FY2023 (-6.67 pp), 64.56% in FY2022 (-3.28 pp) and 67.84% in FY2021 (+1.21 pp).
- The Q2 2026 figure ranks as the lowest quarterly Net Margin since Q2 2015.
- Year over year, Net Margin gained in four of the last six quarters, with an average year-over-year change of +51.89 percentage points.
- The high point for year-over-year Net Margin in five years was Q1 2026 (a gain of 242.97 percentage points); the low point was Q4 2023 (a drop of 272.80 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 190.41% (Q1 2026), 143.22% (Q4 2025) and 83.40% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Innoviva | 1.54 Bn | -748.67 Mn | 90.62 Mn | -69.75% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -69.75% |
| Mar 31, 2026 | 190.41% |
| Dec 31, 2025 | 143.22% |
| Sep 30, 2025 | 83.40% |
| Jun 30, 2025 | 63.51% |
| Mar 31, 2025 | -52.56% |
| Dec 31, 2024 | 22.15% |
| Sep 30, 2024 | 1.36% |
| Jun 30, 2024 | -34.72% |
| Mar 31, 2024 | 47.14% |
| Sep 30, 2023 | 121.99% |
| Jun 30, 2023 | 1.58% |
| Mar 31, 2023 | 45.65% |
| Sep 30, 2022 | 394.79% |
| Jun 30, 2022 | 0.87% |
| Mar 31, 2022 | 17.51% |
| Dec 31, 2021 | 9.61% |
| Sep 30, 2021 | 74.02% |
| Jun 30, 2021 | 88.24% |
| Mar 31, 2021 | 110.06% |
API Access
Innoviva Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();